EL
DGX icon

EMFO LLC’s Quest Diagnostics DGX Stock Holding History

EMFO LLC’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$30.1K Hold
220
– – 0.03% 173
2024
Q1 		$29.3K Hold
220
– – 0.03% 177
2023
Q4 		$30.3K Hold
220
– – 0.03% 173
2023
Q3 		$26.8K Hold
220
– – 0.03% 181
2023
Q2 		$30.9K Hold
220
– – 0.03% 186
2023
Q1 		$31.1K Hold
220
– – 0.03% 188
2022
Q4 		$34.4K Hold
220
– – 0.03% 174
2022
Q3 		$27K Hold
220
– – 0.03% 202
2022
Q2 		$29K Hold
220
– – 0.03% 205
2022
Q1 		$30K Hold
220
– – 0.03% 215
2021
Q4 		$38K Hold
220
– – 0.03% 215
2021
Q3 		$32K Hold
220
– – 0.03% 229
2021
Q2 		$29K Buy
+220
New +$28.8K 0.03% 225

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EMFO LLC's DGX Position: Q2 2024 in Review

EMFO LLC held its Quest Diagnostics (DGX) position steady in Q2 2024 at 220 shares worth $30.1K. The position accounts for 0.03% of the portfolio, ranked #173.

EMFO LLC first reported a position in DGX in Q2 2021 and has held it in 13 quarters since. The position peaked at $38K in Q4 2021. 837 funds tracked by Wall St. Rank hold DGX as of Q2 2024.

  • EMFO LLC held 220 shares of Quest Diagnostics worth $30.1K as of Q2 2024.
  • EMFO LLC left its Quest Diagnostics share count unchanged in Q2 2024.
  • Quest Diagnostics made up 0.03% of EMFO LLC's portfolio in Q2 2024, its #173 holding.
  • EMFO LLC first reported a position in Quest Diagnostics in Q2 2021 and has held it in 13 quarters since.
  • EMFO LLC's Quest Diagnostics position peaked at $38K in Q4 2021.
  • 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.